Agar/β-Cyclodextrin Composite Cryogels for Controlled Release of Aripiprazole
Molecules · 2025
DOI: 10.3390/molecules30051051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Siyka Stoilova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Polymers, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: beta-Cyclodextrins, Agar, Cryogels, Aripiprazole. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program "Research, Innovation and Digitization for Smart Transformation" 2021-2027, co-funded by the EU, Sustainable Utilization of Bio-resources and Waste of Medicinal and Aromatic Plants for Innovative Bioactive Products, Research, Innovation and Digitization for Smart Transformation.
Abstract (Originalsprache)
Aripiprazole (ARZ) is an atypical antipsychotic drug used to treat a variety of mood and psychotic disorders, such as schizophrenia, bipolar disorder, major depressive disorder, autism, and Tourette’s syndrome. Although ARZ offers significant therapeutic benefits, its poor solubility in water requires the development of delivery systems aimed at improving the solubility and bioavailability of the drug. In this work, cryogels based on two natural products—agar and β-cyclodextrin (CD)—were developed and evaluated as a drug delivery system for ARZ. The cryogels were prepared by cryogenic treatment of aqueous solutions of agar and the β-CD/ARZ complex, followed by thawing. The main characteristics of the material, including gel fraction yield, swelling degree, pore volume, elastic properties, and morphology were studied in detail. The release of ARZ from composite cryogels was assessed in two media resembling the pH in stomach and intestine. The system exhibited a pH-dependent release of ARZ, with a slower rate in acidic media (pH 1.2) than in the neutral phosphate buffer (pH 6.8). Under in vitro conditions, the amount of released ARZ over 48 h reached 33%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Polymers, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav St., 1000 Sofia, Bulgaria.
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
- Centre of Competence "Sustainable Utilization of Bio-Resources and Waste of Medicinal and Aromatic Plants for Innovative Bioactive Products" (BioResources), 1000 Sofia, Bulgaria.
ORCID-Profile: Rositsa Mihaylova, Bistra Kostova, Petar D Petrov
Förderung
- Program "Research, Innovation and Digitization for Smart Transformation" 2021-2027, co-funded by the EU
- Sustainable Utilization of Bio-resources and Waste of Medicinal and Aromatic Plants for Innovative Bioactive Products
- Research, Innovation and Digitization for Smart Transformation
Zitieren
APA
Stoilova, S., Georgiev, G. L., Mihaylova, R., Kostova, B., & Petrov, P. D. (2025). Agar/β-Cyclodextrin Composite Cryogels for Controlled Release of Aripiprazole. Molecules. https://doi.org/10.3390/molecules30051051
Vancouver
Stoilova S, Georgiev GL, Mihaylova R, Kostova B, Petrov PD. Agar/β-Cyclodextrin Composite Cryogels for Controlled Release of Aripiprazole. Molecules. 2025. doi:10.3390/molecules30051051
BibTeX
@article{Stoilova2025,
author = {Stoilova, Siyka and Georgiev, Georgy L and Mihaylova, Rositsa and Kostova, Bistra and Petrov, Petar D},
title = {Agar/β-Cyclodextrin Composite Cryogels for Controlled Release of Aripiprazole},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30051051}
}
EUVIMED